San Antonio, TX
United States
University of Texas at San Antonio - Division of Hematology and Medical Oncology
RET mutation, RET fusion, oncogenic fusion, pheochromocytoma, paraganglioma, tyrosine kinase inhibitor, GRB2, driver genetic events, selpercatinib, pralsetinib